Log in to save to my catalogue

De Novo design of potential inhibitors against SARS-CoV-2 Mpro

De Novo design of potential inhibitors against SARS-CoV-2 Mpro

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9197785

De Novo design of potential inhibitors against SARS-CoV-2 Mpro

About this item

Full title

De Novo design of potential inhibitors against SARS-CoV-2 Mpro

Publisher

United States: Elsevier Ltd

Journal title

Computers in biology and medicine, 2022-08, Vol.147, p.105728-105728, Article 105728

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractThe impact of the ravages of COVID-19 on people's lives is obvious, and the development of novel potential inhibitors against SARS-CoV-2 main protease (Mpro), which has been validated as a potential target for drug design, is urgently needed. This study developed a model named MproI-GEN, which can be used for the de novo design of potential...

Alternative Titles

Full title

De Novo design of potential inhibitors against SARS-CoV-2 Mpro

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9197785

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9197785

Other Identifiers

ISSN

0010-4825

E-ISSN

1879-0534

DOI

10.1016/j.compbiomed.2022.105728

How to access this item